跳到正文
原文
Medical Xpress·· 2026-10-08精选AI 评分63

欧洲皮肤科年会研究:自主AI可将皮肤科医生临床容量提升62%

Autonomous AI can increase clinical capacity for dermatologists

AI 导读

一项提交至欧洲皮肤病与性病学会年会的研究显示,在两家医院实施的自主AI医疗器械处理了8,391例紧急皮肤癌患者,同意自主决策的比例为86%,AI实际自主放行率分别为31%和25%,常规随访和活检率均较传统路径下降,估算节省临床时间2,851小时,相当于临床容量提升62%。研究团队认为自主AI的价值在于释放专科医生容量。

推荐理由

研究展示了自主AI在真实皮肤癌诊疗路径中的放行率与节省工时,对评估其临床价值有参考意义。

正文 · 原文
EADV: Autonomous AI can increase clinical capacity for dermatologists

Autonomous artificial intelligence (AI) in urgent skin cancer pathways can increase clinical capacity for dermatologists, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 30 to Oct. 3 in Vienna.

Lucy Thomas, M.B.Ch.B., from Imperial College London, and colleagues implemented class III artificial intelligence as a medical device (AIaMD) across two hospital sites. Sequential validation was applied (dermoscopic confirmation and image quality assessment), followed by hierarchical classification prioritizing higher-risk diagnoses.

Cases classified as benign were discharged autonomously, without clinician review, while high-risk cases were triaged for assessment by a teledermatologist (TD). To assess diagnostic performance, outcomes were compared with face-to-face (F2F), TD-only and AI-assisted TD pathways.

Overall, 8,391 patients were managed via the autonomous pathway; the consent rate for autonomous decision-making was 86%. The researchers found that autonomous AIaMD discharge rates were 37% and 32% at sites 1 and 2, respectively, with actual discharge rates of 31% and 25%, respectively, after exclusions; TD discharged an additional 24% and 25%, respectively.

Routine follow-up was reduced with autonomous AIaMD versus standard TD (12% versus 27%), while the biopsy rate was reduced compared with conventional F2F care (26% to 29% versus 43%). False negatives were rare; no adverse outcomes were identified within available follow-up. Compared with the F2F pathways, estimated clinician time savings were 2,851 hours, representing a 62% gain in clinical capacity.

"We believe the greatest value of autonomous AI lies not in the technology itself, but in the specialist capacity it unlocks," Thomas said in a statement.

Key medical concepts

Skin Cancer

Clinical categories

Dermatology

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Alexander Pol

Alexander Pol

PhD nano-engineering from Delft University. Published researcher and journal reviewer. Brings scientific insight to content standards. Full profile →

Copyright © 2026 HealthDay. All rights reserved.

Citation: Autonomous AI can increase clinical capacity for dermatologists (2026, October 7) retrieved 7 October 2026 from https://medicalxpress.com/news/2026-10-autonomous-ai-clinical-capacity-dermatologists.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com